These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6465 related articles for article (PubMed ID: 3511357)

  • 61. Beneficial and adverse side-effects of hormonal contraception.
    Pepperell RJ
    Med J Aust; 1986 Feb; 144(4):169-70. PubMed ID: 3945215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prescription contraceptives: countering the risks.
    Ruggiero RJ
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oral contraceptives in relation to breast cancer.
    Malone KE; Daling JR; Weiss NS
    Epidemiol Rev; 1993; 15(1):80-97. PubMed ID: 8405215
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Breast cancer risk in relation to type of estrogen contained in oral contraceptives.
    Schlesselman JJ; Stadel BV; Murray P; Lai SH
    Contraception; 1987 Dec; 36(6):595-613. PubMed ID: 3446437
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral contraceptives and neoplasia: 1987 update.
    Huggins GR; Zucker PK
    Fertil Steril; 1987 May; 47(5):733-61. PubMed ID: 3552751
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oral contraceptive use and cervical intraepithelial neoplasia.
    Coker AL; McCann MF; Hulka BS; Walton LA
    J Clin Epidemiol; 1992 Oct; 45(10):1111-8. PubMed ID: 1474407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral contraceptives and breast cancer.
    Thomas DB
    J Natl Cancer Inst; 1993 Mar; 85(5):359-64. PubMed ID: 8433389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An update on the pill.
    Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.
    Rosenberg MJ; Waugh MS; Meehan TE
    Contraception; 1995 May; 51(5):283-8. PubMed ID: 7628201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term health risks and benefits of oral contraceptive use.
    Peterson HB; Lee NC
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):775-88. PubMed ID: 2092241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours.
    Milne R; Vessey M
    Contraception; 1991 Jun; 43(6):667-93. PubMed ID: 1868737
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oral contraceptives and cancer.
    FDA Drug Bull; 1984 Apr; 14(1):2-3. PubMed ID: 6734989
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
    Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
    Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Breast cancer and oral contraceptives: a review.
    Clavel F; Benhamou E; Sitruk-Ware R; Mauvais-Jarvis P; Flamant R
    Contraception; 1985 Dec; 32(6):553-69. PubMed ID: 3912104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 324.